Moreover, it has been reported that the T cells activated by radiotherapy are recruited to new tumor sites by the CXCL10 secreted by tumor cells,[51] and the release of HMGB1 facilitates the synthesis of pro‐inflammatory factors, including type I interferons, subsequently guiding CXCL10 production. Here, CXCL10 is linked to neoplasm.